|
|
Post by mssciguy on Oct 12, 2015 19:13:28 GMT -5
It's from a local SmartUps emarketing talk (SmartUps is the Meetup for local startups). I am not sure that you really need a study or survey to convince yourself-- look at TV ads, radio ads, internet ad, it's all repetition. From my own experiments in emarketing, I can tell you for sure that in the absence of deep discounts, 10-20 page views gets one sale (although what I had was unique). Maybe Afrezza is unique enough to get sold without all that repetition. But then, maybe it will take more. Too early to tell, and Pfizer poisoned the well in some ways with their product. I spend a ton of money on marketing from all different avenues. Mail, magazine seo leads. People directly reaching out to me in my industry will yield 5-8% close ratio. I have mailed ten thousands pieces and receive call back response of .25% to 1%. I would be a millionaire with ease of 20 views got me a sale. Do you ever get the feeling that some of the board contributors here could be of great benefit to Sanofi? Myself--- 30 years exp in govt, pharma and more, and you and many others have backgrounds that are not exactly pedestrian... and btw, will msg you, would love to know more if you don't mind |
|
|
|
Post by kball on Oct 12, 2015 20:53:41 GMT -5
I'm still long. But increasingly concerned. Any catalysts on the horizon? Anyone notice that volume has slowed to a trickle? I don't like it. Aren't many funds precluded from buying stocks under $5.00? |
|
|
|
Post by thekindaguyiyam on Oct 12, 2015 21:28:50 GMT -5
I'm still long. But increasingly concerned. Any catalysts on the horizon? Anyone notice that volume has slowed to a trickle? I don't like it. Aren't many funds precluded from buying stocks under $5.00? the banks were closed today. You may want to reverse your order of importance given your decaying appearance. Start with therapy; drink, take a walk.... anything. I'm tired of coloring your hair in with a permanent marker on my powerbook! If that doesn't do it... walk away and take a vacation; the company will still be here when you get back. |
|
|
|
Post by jpg on Oct 13, 2015 0:05:35 GMT -5
Anyone notice that volume has slowed to a trickle? I don't like it. Aren't many funds precluded from buying stocks under $5.00? the banks were closed today. You may want to reverse your order of importance given your decaying appearance. Start with therapy; drink, take a walk.... anything. I'm tired of coloring your hair in with a permanent marker on my powerbook! If that doesn't do it... walk away and take a vacation; the company will still be here when you get back. Funny you say that. I took a 3 week camping/ backpacking vacation a few weeks ago and rarely looked at this board, the company share price or script count and as you stated the company was still there when I got back! Hard to believe no? And I slept very well... |
|
|
|
Post by mbseeking on Oct 13, 2015 4:35:56 GMT -5
Yes, a little bit of advertising might be nice. A while back I was checking google trends on afrezza. Bit erratic so dropped it. But just for the fun of it I just did again, and mashed in toujeo as well for fun. Oh dear. Not sure if this link will work www.google.com/trends/explore#q=afrezza%2C%20toujeo&cmpt=q&tz=Etc%2FGMT-7 ..but you can line up afrezza and toujeo for yourself on google/trends. Look how many people have started searching on Toujeo! Looks like Sanofi knows how to get interest in a product. Just hope they decide to do it for afrezza too. And soon. Afrezza is dying on the google trends vine. |
|
|
|
Post by kball on Oct 13, 2015 8:20:43 GMT -5
the banks were closed today. You may want to reverse your order of importance given your decaying appearance.Start with therapy; drink, take a walk.... anything. I'm tired of coloring your hair in with a permanent marker on my powerbook! If that doesn't do it... walk away and take a vacation; the company will still be here when you get back. the company share price or script count and as you stated the company was still there when I got back! Hard to believe no? And I slept very well... Good advice kindaguy. I do 3-5 miles most every morning. Being outdoors definitely helps. Might just need to stay away from the market and computers for a while like jpg. Maybe Yosemite or the NP's in Utah. My timing in biotechs has always been poor and i've been shaken out at least 3 times in others before huge gains (amgen, Biogen, Amylin) and i don't want that to happen here |
|
|
|
Post by newmnkdinvestor on Oct 13, 2015 18:32:07 GMT -5
I spend a ton of money on marketing from all different avenues. Mail, magazine seo leads. People directly reaching out to me in my industry will yield 5-8% close ratio. I have mailed ten thousands pieces and receive call back response of .25% to 1%. I would be a millionaire with ease of 20 views got me a sale. Do you ever get the feeling that some of the board contributors here could be of great benefit to Sanofi? Myself--- 30 years exp in govt, pharma and more, and you and many others have backgrounds that are not exactly pedestrian... and btw, will msg you, would love to know more if you don't mind I feel like my experience in marketing my product actually has me even more rattled about my invest with MNKD. |
|
|
|
Post by dreamboatcruise on Oct 13, 2015 19:05:12 GMT -5
I stick to my comment about October 15th + or - days which will put us into the 3rd Qtr conference call. Matt was pretty Matter of fact on the Ageis call the other day. Perhaps its my gut instinct that he was hiding some news. Perhaps not. I did like they way he addressed debt issue. Lets face it MannKind could have issued a press release on the finalization of the Debt issue but didn't. I like that game of poker that Matt is playing. I guess we don't know anything "YET!"
(please tell me that I am a crazy delusional MannKind pumper for my view above) I can take it. Crazy is a bit harsh. What's the equivalent of rose colored glasses for an audio only conference feed? |
|
|
|
Post by kball on Oct 13, 2015 19:26:17 GMT -5
I stick to my comment about October 15th + or - days which will put us into the 3rd Qtr conference call. Matt was pretty Matter of fact on the Ageis call the other day. Perhaps its my gut instinct that he was hiding some news. Perhaps not. I did like they way he addressed debt issue. Lets face it MannKind could have issued a press release on the finalization of the Debt issue but didn't. I like that game of poker that Matt is playing. I guess we don't know anything "YET!"
(please tell me that I am a crazy delusional MannKind pumper for my view above) I can take it. Crazy is a bit harsh. What's the equivalent of rose colored glasses for an audio only conference feed?A Scienceologist? |
|
